Mark Bodenrader - Senior Vice President, Finance and Chief Accounting Officer at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Senior Vice President, Finance and Chief Accounting Officer
Stock Symbol
CERE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark Bodenrader - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Mark Bodenrader for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct Common Stock
Stock Option (Right to Buy) 0 Aug 1, 2024 Direct Common Stock

Transactions reported by Mark Bodenrader for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.